What the Fujifilm TV commercial - Artificial Intelligence and Breast Cancer Detection is about.
Fujifilm has recently released a TV spot that showcases their innovative technology in the realm of breast cancer detection. The ad starts by highlighting the alarming statistics regarding breast cancer, with one in eight women being diagnosed with the disease at some point in their lives.
The focus then shifts to Fujifilm's artificial intelligence technology, which is introduced as a groundbreaking tool that helps in the early detection of breast cancer. The ad goes on to explain that this technology uses computer algorithms to analyze mammograms and detect any potential abnormalities, allowing for a more accurate and efficient diagnosis.
The TV spot also features testimonials from real women who have benefited from this technology, including a breast cancer survivor who speaks about how early detection ultimately saved her life.
Overall, Fujifilm's TV spot is a powerful and inspiring message about the importance of early detection in the fight against breast cancer. The use of innovative technology such as AI is presented as a key tool in this fight, showcasing the potential of technology to have real-world impact in the healthcare sector.
Fujifilm TV commercial - Artificial Intelligence and Breast Cancer Detection produced for
Fujifilm
was first shown on television on April 5, 2022.
Frequently Asked Questions about fujifilm tv spot, 'artificial intelligence and breast cancer detection'
The AI software creates a mathematical representation - an algorithm - of what a normal mammogram looks like and what a mammogram with cancer looks like. The AI system can see more detail in each mammogram than the human eye can, and checks each image against the standards to find any abnormalities.
The AI was also used to highlight suspicious findings on the images. The team showed that the AI detected 20% more cancers than were found using the conventional procedure, without increasing the number of false-positive readouts. The AI also reduced radiologists' workload by 44%.
Even AI algorithms trained for short time horizons (as low as three months) were able to predict the future risk of cancer up to five years when no cancer was clinically detected by screening mammography. When used in combination, the AI and BCSC risk models further improved cancer prediction.
The interim results, published in the Lancet Oncology late Tuesday, found that using AI-supported analysis of mammograms, alongside either one or two radiologists, was as good as using two radiologists without AI and led to 20 percent more cancers being detected.
The most commonly used breast imaging tests at this time are mammograms, ultrasound, and breast MRI. Other tests, such as CT scans, bone scans, or PET scans might sometimes be done to help find out if breast cancer has spread.
The Static Droplet Microfluidic device is able to rapidly detect circulating tumour cells that have broken away from a primary tumour and entered the bloodstream. The device uses a unique metabolic signature of cancer to differentiate tumour cells from normal blood cells.
Mammograms are among the best breast cancer diagnostic tools, with about 87% accuracy depending on your age and breast density.
Regular mammograms are the best tests doctors have to find breast cancer early. A mammogram is an X-ray picture of the breast. Doctors use a mammogram to look for early signs of breast cancer. Regular mammograms can find breast cancer early, sometimes up to three years before it can be felt.
Advancements in AI cancer detection
For patients undergoing screening for lung cancer, Sybil was able to look at an image and accurately predict the risk of a patient developing lung cancer within six years.
Hungarian physicians are using an artificial intelligence model that can detect breast cancer four years before it develops, The New York Times reported March 7. Called computer-assisted detection, the AI identifies spots in mammograms for physicians to inspect closely.
Aromatase inhibitors are a type of hormone therapy drug used to treat breast cancer in women who have gone through a natural menopause (when periods stop). It can also be used in premenopausal women having ovarian suppression . The three aromatase inhibitor drugs are: Letrozole. Anastrozole.
Technological advances in imaging are creating new opportunities for improvements in both screening and early detection. One technology advance is 3-D mammography, also called breast tomosynthesis. This procedure takes images from different angles around the breast and builds them into a 3-D-like image.